バイオフィルムのバクテリアの抗生物質耐性
1Center for Biofilm Engineering and Department of Chemical Engineering, Montana State University, Bozeman, MT 59717-3980, USA. phil_s@erc.montana.edu
Lancet (London, England)
|July 21, 2001
まとめ
医療機器のバクテリアバイオフィルムは,個々の細胞耐性とは異なるユニークな多細胞耐性戦略のために慢性感染症を引き起こす. これらのバイオフィルムメカニズムを理解することは,新しい治療法の開発の鍵です.
科学分野:
- 微生物学 微生物学とは
- 感染症 感染症は感染症です.
- バイオメディカルエンジニアリング
背景:
- 細菌は,植入された医療機器や損傷した組織に,生体フィルム,保護的な粘性層を形成します.
- バイオフィルム感染症はしばしば慢性であり,高い抗生物質耐性のために治療が困難である.
- 個々の細菌における既存の抗生物質耐性メカニズムは,バイオフィルムで観察されたものとは異なる.
研究 の 目的:
- バイオフィルム感染症の特徴を要約するために.
- バイオフィルムにおける抗生物質耐性の新興メカニズムを見直す.
- バイオフィルム感染に対する潜在的な治療戦略について議論する.
主な方法:
- バイオフィルム感染症と耐性メカニズムに関する文献レビュー.
- バイオフィルム抵抗に寄与する多細胞戦略の分析.
- 現在のおよび将来の治療アプローチの探索.
主要な成果:
- バイオフィルムは,バクテリア感染の治療においてユニークな課題を提示します.
- バイオフィルムの抗生物質耐性は,個々の細胞の特徴ではなく,多細胞の適応に起因する.
- これらの複雑な抵抗機構の理解から,新たな治療目標が生まれています.
結論:
- バイオフィルム感染症は,明確な治療アプローチを必要とする重要な臨床的課題を代表しています.
- 多細胞抵抗は,バイオフィルム内の細菌の特徴です.
- バイオフィルム固有の耐性メカニズムに関するさらなる研究は,効果的な治療法の開発に不可欠です.
さらに関連する動画
関連する概念動画
Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


